Announcements
- 2025.10.31 CLARIFICATION ANNOUNCEMENT
- 2025.10.29 VOLUNTARY ANNOUNCEMENT UPDATE ON RESULTS OF CLINICAL STUDIES OF THE COMPANY'S MULTI-PRODUCT PORTFOLIO ARE RELEASED AT TCT 2025 IN THE U.S., INCLUDING THE LUX-VALVE PLUS TRINITY STUDY, JENSCLIP CLINICAL STUDY, AND KEN-VALVE CLINICAL STUDY
- 2025.10.28 VOLUNTARY ANNOUNCEMENT REMARKABLE RESULTS OF CLINICAL STUDIES OF THE COMPANY'S MULTI-PRODUCT PORTFOLIO ARE RELEASED AT TCT 2025 IN THE U.S., INCLUDING THE LUX-VALVE PLUS TRINITY STUDY, JENSCLIP CLINICAL STUDY, AND KEN-VALVE CLINICAL STUDY
- 2025.10.15 POLL RESULTS OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING
- 2025.10.09 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS APPROVED FOR HONG KONG-MACAO MEDICINE AND EQUIPMENT CONNECT
- 2025.10.08 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
- 2025.09.29 SUPPLEMENTAL ANNOUNCEMENT REGARDING CANCELLATION OF BOOK CLOSURE PERIOD
- 2025.09.26 PROXY FORM FOR THE 2025 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON OCTOBER 15, 2025
- 2025.09.26 NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING
- 2025.09.26 (I) PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE SHARES; AND (2) NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
